Drugs for the treatment of COVID-19 are in desperate need world-wide. A rapid drug discovery platform that can help identify drugs for the treatment of COVID-19 is essential for identifying viable treatments.   Based on a joint research effort, Applied Biology and Brown University researchers concluded that the androgen receptor may be implicated in COVID-19 mortality risk. Therefore, human type II pneumocytes androgen sensitivity should be tested as a potential treatment marker. The team led by...